Showing 53,641 - 53,660 results of 330,355 for search '"diseases"', tempo de consulta: 0.87s Limitar resultados
  1. 53641
  2. 53642

    Serial MRI Features of Canine GM1 Gangliosidosis: A Possible Imaging Biomarker for Diagnosis and Progression of the Disease por Daisuke Hasegawa, Osamu Yamato, Yuya Nakamoto, Tsuyoshi Ozawa, Akira Yabuki, Kazuhito Itamoto, Takayuki Kuwabara, Michio Fujita, Kimimasa Takahashi, Shunta Mizoguchi, Hiromitsu Orima

    Publicado 2012-01-01
    “...GM1 gangliosidosis is a fatal neurodegenerative lysosomal storage disease caused by an autosomal recessively inherited deficiency of β-galactosidase activity. ...”
    Ligazón do recurso
    Artigo
  3. 53643

    Mapping the distribution of Lyme disease at a mid-Atlantic site in the United States using electronic health data. por Paul M Lantos, Mark Janko, Lise E Nigrovic, Felicia Ruffin, Takaaki Kobayashi, Yvonne Higgins, Paul G Auwaerter

    Publicado 2024-01-01
    “...We used two sources of cases: a) individuals with both a positive test for Lyme disease and a contemporaneous diagnostic code consistent with a Lyme disease-related syndrome; and b) individuals referred for a Lyme disease evaluation who were adjudicated to have Lyme disease. ...”
    Ligazón do recurso
    Artigo
  4. 53644
  5. 53645
  6. 53646
  7. 53647
  8. 53648

    The Risk Factors and Predictors of Chronic Obstructive Pulmonary Disease in Patients With Obstructive Sleep Apnea–Hypopnea Syndrome at Plateau por Yumei Geng, Yu Hu, Bin Li, Zhuoma Dawa, Fang Zhang

    Publicado 2025-02-01
    “...ABSTRACT Background OSAHS patients with COPD (i.e., overlap syndrome) have a significantly worse prognosis than those with OSAHS alone, and the role of plateau hypoxia in the occurrence of the disease is still unclear. This underscores the urgent need to explore the risk factors for the incidence of COPD in patients with OSAHS and to identify predictors for the occurrence of overlap syndrome at plateau. ...”
    Ligazón do recurso
    Artigo
  9. 53649

    Characterizing alcohol-related and metabolic dysfunction-associated steatotic liver disease cirrhosis via fibrotic pattern analysis por Masanori Fukushima, Hisamitsu Miyaaki, Yasuhiko Nakao, Ryu Sasaki, Masafumi Haraguchi, Kosuke Takahashi, Eisuke Ozawa, Satoshi Miuma, Yuko Akazawa, Akihiko Soyama, Susumu Eguchi, Shinji Okano, Kazuhiko Nakao

    Publicado 2024-10-01
    “...Abstract This study aimed to address the diagnostic challenges in distinguishing between alcohol-related liver disease (ALD) and metabolic dysfunction-associated steatotic liver disease (MASLD). ...”
    Ligazón do recurso
    Artigo
  10. 53650
  11. 53651

    MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPKα por Yuanjie Yu, Chunping He, Shiyun Tan, Mengjun Huang, Yitian Guo, Ming Li, Qian Zhang

    Publicado 2021-01-01
    “...Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide and can develop to nonalcoholic steatohepatitis and later hepatic cirrhosis with a high prevalence to hepatocellular carcinoma. ...”
    Ligazón do recurso
    Artigo
  12. 53652
  13. 53653
  14. 53654
  15. 53655
  16. 53656
  17. 53657

    Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease. por Candice Alexandra Grzelak, Nicholas David Sigglekow, Janina Elke Eleonore Tirnitz-Parker, Elizabeth Jane Hamson, Alessandra Warren, Bharvi Maneck, Jinbiao Chen, Bramilla Patkunanathan, Jade Boland, Robert Cheng, Nicholas Adam Shackel, Devanshi Seth, David Geoffrey Bowen, Luciano Gastón Martelotto, D Neil Watkins, Geoffrey William McCaughan

    Publicado 2017-01-01
    “...At least two mechanisms of GLI signaling (Pc/SMO-dependent and Pc/SMO-independent) mediate chronic liver disease pathogenesis. This may have significant ramifications for the choice of Hh inhibitor (anti-SMO or anti-GLI) suitable for clinical trials. ...”
    Ligazón do recurso
    Artigo
  18. 53658

    Association of Succinate and Adenosine Nucleotide Metabolic Pathways with Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus por Inha Jung, Seungyoon Nam, Da Young Lee, So Young Park, Ji Hee Yu, Ji A Seo, Dae Ho Lee, Nan Hee Kim

    Publicado 2024-11-01
    “...Background Although the prevalence of diabetic kidney disease (DKD) is increasing, reliable biomarkers for its early detection are scarce. ...”
    Ligazón do recurso
    Artigo
  19. 53659

    The Achievements and Challenges of Mesenchymal Stem Cell-Based Therapy in Inflammatory Bowel Disease and Its Associated Colorectal Cancer por Dickson Kofi Wiredu Ocansey, Wei Qiu, Jingyan Wang, Yongmin Yan, Hui Qian, Xu Zhang, Wenrong Xu, Fei Mao

    Publicado 2020-01-01
    “...It is known that people who have Inflammatory Bowel Disease (IBD) turn to be prone to increased risks of developing colorectal cancer (CRC), which has global incident and mortality rates of 10.2% and 9.2%, respectively. ...”
    Ligazón do recurso
    Artigo
  20. 53660